Danone's Open Innovation Model
Danone's Irini Schoeman-Giziakis discusses open innovation, nutrition, and artificial intelligence with AgFunderNews.
The company is exploring the GLP-1 era and its implications on nutrition. According to Schoeman-Giziakis, it's still early days, but Danone is focused on meeting the nutritional needs of people taking GLP-1 drugs or trying to retain weight loss after stopping them.
- Danone is considering how to position its existing products to meet the needs of GLP-1 patients.
- The company may use nutrition or online shopping apps to guide patients towards suitable products.
It's early days, but Danone is primarily focused on meeting the nutritional needs of people taking these drugs or trying to retain weight loss after coming off them.
Author's summary: Danone explores open innovation and GLP-1 era nutrition.
More News
- John Travolta Proves He’s Still Got the Moves with a Legendary Dance Lesson on The Late Late Show
- Police rule out terrorism in stabbing attack on UK train after 2 men are arrested
- Common Drugs Can Rewire Your Gut For Several Years, Study Finds
- Donald Trump slams Seth Meyers again, calling him “The Least Talented Person on TV” | Al Bawaba
- Home record alive as Phoenix take down Wildcats
- Kansas State football's blunders vs Texas Tech reminds of season's frustrations | Wheeler